Bristol-Myers Squibb Co at Wolfe Research Inaugural Healthcare Conference Transcript
All right. We're going to go ahead and begin. You want to make sure that microphone -- we'll see. Maybe it's fine. Sometimes (inaudible) in this room. So happy to be here with Bristol-Myers. Well, I'm Tim Anderson, the pharma analyst at Wolfe. We have Giovanni Caforio, who's the CEO and Chairman of the Board. He's been with the company since 2000 and prior to that his 12 years at Abbott Labs. He's also the current Chairman of the PhRMA Board of Directors, so PhRMA being the trade organization. And you've been in that position for maybe a year?
Since September 1. So less than a year.
Questions & Answers
Okay. So I thought we'd start off with some general questions. And a lot of these initial questions are going to be on the transaction that's pending with Celgene, as you might imagine. So let
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
